U.S. Court of Appeals for the Federal Circuit, 2011

In Re Rosuvastatin Calcium Patent Litigation

In Re Rosuvastatin Calcium Patent Litigation
U.S. Court of Appeals for the Federal Circuit · Decided May 19, 2011

In Re Rosuvastatin Calcium Patent Litigation

Opinion

NOTE: This order is nonprecedential United States Court of Appeals for the FederaI Circuit IN RE ROSUVASTATIN CALCIUM PATENT LITIGATION ' ASTRAZENE CA UK LIMITED, IPR PHARMACEUTICALS INC., AND SHIONOGI SEIYAKU KABUSHIKI KAISHA, Plaintiffs-Appellees, V. AUROBINDO PHARMA LIMITED, Defenclant-Appellant, AND MYLAN PHARMACEUTICALS INC., Defen.ciant-Appellan,t, AND APOTEX CORP., Defendant-Appellant, AND COBALT PHARM,ACEUTICALS INC. AND COBALT LABORATORIES INC., Defen,dants~Appellants, AND SUN PHARMACEUTICAL INDUSTRIES, LTD., Defen,dant~Appellant, ASTRAZENECA V. AU`ROBINDO 2 AND TEVA PHARMACEUTICALS USA, INC., Defendant-Appellant, AND PAR PHARMACEUTI CAL, INC., Defen,dc1nt-Appellant, AND SANDOZ, INC., Defen,dant.

2010-1460, -1461, -1462, -1463, -1464, -1465, -1466, -1467, -1468, -1469, -147O, -1471, -1472, -1473 Appeals from the United States District C0urt for the District of Delaware in case nos. 08-MD-1949, 07-CV- 0810, 07-CV-O805, 07-CV-0809, 07-CV-0811, 07-CV-0806, 08-CV-0426, and 07-CV-0808, Judge Joseph J. Farnan, Jr. ON MOTION ORDER Upon consideration of Par Pharn1aceutica1, Inc.’s mo- tion to withdraw Dutch Chung as principal counse1, IT ls 0RDERED THAT: (1) The motion is granted (2) Par’s principal counsel must promptly enter a new entry of appearance.

HAY 1 9 2011 Date cc: Charles E. Lipsey, Esq.

Robert B. Breisblatt, Esq.

Jefirey S. Ward, Esq.

Steven A. MaddoX, Esq.

Wil1ia1n A. Rak0czy, Esq.

Dutch Chung, Esq.

Nic0le W._ Staff0rd, Esq.

Jan1es F. Hurst, Esq.

Jeffry M. Nich0ls, Esq. s21 AsTRAzENEcA v. AURoB1NDo FoR THE CoURT /s/ J an Horbal__\; J an Horbaly C1erk l.S. C0UR1F FOR THE FEDERAL C|RCUlT f‘|AY-1 9 2011 .|ANl'|0RB4\LY CLE1i lo

Case-law data current through December 31, 2025. Source: CourtListener bulk data.